North Carolina Mounjaro Stomach Paralysis Lawsuit Update (2024)

Quick Summary

• If you are in North Carolina and experiencing stomach paralysis after using Mounjaro, it is essential to be informed about the ongoing North Carolina Mounjaro stomach paralysis lawsuit. Individuals across the state are pursuing compensation for significant side effects, making it crucial to understand your legal options.
• This article will guide you through the latest developments, how to join the North Carolina Mounjaro stomach paralysis lawsuit, and what to expect next.
• If you or someone you know has been affected by complications from Mounjaro, Schmidt & Clark, LLP, is here to assist you. Renowned for our proficiency in plaintiff representation, our main objective is to ensure you obtain the justice and compensation you rightfully deserve.

How S&C Can Help With Your Claim?

S&C can help with your claim by guiding you through the challenging process of pharmaceutical litigation, especially if you’re already dealing with health issues.

Specializing in pharmaceutical litigation, S&C will assist you in filing a stomach paralysis lawsuit related to stomach paralysis caused by diabetes medications like Mounjaro.

S&C Law Firm provides the following services:

• Initial consultations are free of charge.
• Confidentiality during case evaluation.
• A team of attorneys who will fight to secure compensation for your pain and suffering, medical expenses, and other losses.

Mounjaro Stomach Paralysis Lawsuit

The legal landscape surrounding Mounjaro in North Carolina is evolving rapidly. A recent motion was filed to consolidate various federal cases involving the drug into multidistrict litigation (MDL).

At the helm of these proceedings is Judge Karen Spence Marston, who has been tasked with steering the organizational status of the MDL, ensuring that justice is served efficiently. The lawsuits have surged as users seek to recover from the financial toll of serious side effects.

The litigation, part of a broader Ozempic MDL that includes drugs like Ozempic, Wegovy, and Trulicity, underscores the gravity of the claims against Mounjaro involving Ozempic and Wegovy, leading to a potential Ozempic class action lawsuit.

What is Mounjaro?

According to Healthline, Mounjaro is a prescription medication that serves as a beacon of hope for adults struggling with type 2 diabetes. It aims to enhance blood sugar control alongside diet and exercise [1].

Marketed under the brand name Mounjaro, tirzepatide is its scientific moniker. It is a symbol of modern medical innovation for glycemic control and significant weight loss in those with an elevated BMI.

As one of the latest diabetes drugs and a potential weight loss drug, Ozempic and Mounjaro offer a promising solution for better health management. Thus, there are two important weight loss drug options in the fight against diabetes and in treating obesity.

Notably, Mounjaro is the first on the market to act as a dual GIP and GLP-1 receptor agonist, making it a unique player in the treatment of diabetes.

Was Mounjaro Recalled?

Mounjaro was not recalled amid the swirling controversy and litigation. The answer, as of early 2024, is a resounding no. However, the absence of a recall does not equate to a clean bill of health, as the ongoing lawsuits and FDA warnings raise a red flag about safety and potential severe side effects.

Recent reports are concerning: up to December 31, 2023, the FDA Adverse Events Reporting System has flagged 25,126 Mounjaro-related cases, with 2,000 marked as serious, contributing to 74 fatalities [2].

Studies like the SURPASS-2 trial have revealed a slightly higher rate of serious side effects for Mounjaro compared to its peers.

This wave of adverse events, including adverse reactions, signals the need for ongoing research into the drug’s link to gastroparesis and other increased risk of health issues.

As healthcare providers continue to prescribe Ozempic, it is crucial to monitor the legal developments around these medications, especially for those who have been prescribed Ozempic.

In the vast world of pharmaceuticals, it’s crucial to pay attention to FDA warnings. For Mounjaro, these warnings highlight risks such as pancreatitis, kidney issues, and severe stomach problems. The manufacturer, Eli Lilly, finds itself under legal scrutiny, accused of failing to provide adequate warnings about the risks of gastroparesis.

Ensuring patient safety is a shared responsibility between drug manufacturers like Novo Nordisk and Eli Lilly and the Food and Drug Administration (FDA). Yet, these recent developments suggest a breach of this duty of care.

Side Effects of Mounjaro

The side effects of Mounjaro are serious and can range from:

• organ failure
• low blood sugar
• pancreatitis
• gastroparesis (stomach paralysis)

The medication’s impact can be severe, with lawsuits homing in on Mounjaro’s role in causing such injuries.

According to Mana, victims of Mounjaro-induced gastroparesis often recount a harrowing array of symptoms, including [3]:

• bloating
• abdominal pain
• nausea
• diarrhea
• constipation

The disrupted digestive process leads to a diminished appetite and a host of severe gastrointestinal issues that can significantly impair quality of life.

How Do You Qualify for a Mounjaro Stomach Paralysis Lawsuit?

To qualify for a Mounjaro stomach paralysis lawsuit, you must be able to prove that you have suffered from the drug’s side effects and that the manufacturer failed to warn about these dangers adequately. Eligible individuals are those who have experienced severe gastrointestinal issues, such as gastroparesis, after using Mounjaro.

The allegations against Eli Lilly are serious, with claims that they:

• knew but did not adequately inform the public of the severe gastrointestinal issues associated with Mounjaro
• failed to conduct proper testing and research on the drug’s potential side effects
• prioritized profits over the safety and well-being of consumers

In light of these allegations, Ozempic stomach paralysis lawsuits have also gained attention as individuals seek justice for their suffering.

As a result of using the defendants’ Ozempic and Mounjaro, the plaintiff was caused to suffer from severe gastrointestinal events – Jennifer Chesak, MSJ, Medical Journalist for Healthline

The Status Of The Mounjaro Lawsuit Litigation in North Carolina

The Mounjaro lawsuit litigation in North Carolina is still in its early stages. No settlements have been reached, and trials are yet to be scheduled, but the number of cases is on the rise as more individuals come forward with life-altering side effects.

The recent addition of a plaintiff, Sandra Linney, highlights the personal toll these cases take, while Judge Pratter’s untimely passing has introduced unexpected delays.

Multidistrict Litigation (MDL) for Mounjaro Cases

Multidistrict litigation (MDL) serves as a beacon of efficiency in the legal system, consolidating related cases to streamline the process and ensure consistent rulings.

For Mounjaro cases, the formation of an MDL is a strategic move to:

• Manage the growing body of lawsuits effectively
• Reduce duplicative discovery and conflicting rulings
• Promote efficiency and consistency in the litigation process
• Facilitate settlement negotiations and potential resolution

Mounjaro Lawsuit Settlement Amounts in North Carolina

While the ink has yet to dry on any settlement agreements, the potential compensation range for a successful Mounjaro lawsuit is estimated between $400,000 and $700,000, depending on the severity of the gastroparesis and other damages.

This figure accounts for economic losses like medical bills and lost income, as well as non-economic losses, including the value of pain and suffering.

Filing a Mounjaro Stomach Paralysis Lawsuit in North Carolina

Embarking on the legal journey of filing a Mounjaro stomach paralysis lawsuit in North Carolina is similar to the Ozempic stomach paralysis lawsuit. It involves establishing the manufacturer’s failure to warn and presenting compelling evidence to support your case.

The evidence must be watertight, showing that users and their physicians were not properly informed about the risks associated with Mounjaro.

Types of Evidence To Present

The types of evidence presented can make or break a case in the quest for justice. Medical records are the cornerstone, providing a detailed account of the diagnosis and treatment of stomach paralysis.

Expert testimony can be the wind in the sails, establishing a connection between Mounjaro and the onset of stomach paralysis, which may lead to an Ozempic stomach paralysis claim.

What is the Statute of Limitations for the Mounjaro Lawsuit in North Carolina?

The statute of limitations for the Mounjaro lawsuit in North Carolina is three years from the date of injury or its discovery. However, this timeframe can vary, highlighting the importance of consulting a lawyer promptly to avoid missing the deadline.

Related Articles:

• Utah Mounjaro Stomach Paralysis Lawsuit
• Maryland Mounjaro Stomach Paralysis Lawsuit
• Pennsylvania Mounjaro Stomach Paralysis Lawsuit

See all related dangerous drug lawsuits our attorneys covered so far.

Get Your Free Consultation From Our North Carolina Lawyers

The Schmidt & Clark, LLP law firm is here to support you during these challenging times. If you or a loved one has suffered from gastrointestinal disorders due to weight loss drugs such as Mounjaro, don’t hesitate to reach out to us.

Our team has extensive experience in handling such cases and will guide you through the legal process. We will provide clarity regarding your rights and assess your eligibility for a lawsuit related to these complications.

Get a free case evaluation, and remember, we only charge fees if we successfully win your case. You can trust that our commitment to your case is as strong as if you were part of our own family. Contact us today for a comprehensive review of your concerns.

Reference:

1. https://www.healthline.com/health/drugs/mounjaro
2. https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system
3. https://mana.md/understanding-gastroparesis/